Vaxart to Present at the SVB Leerink CybeRx Series: Vaccine Forum
SOUTH SAN FRANCISCO, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that its executive officers, Andrei Floroiu, CEO, and Sean Tucker, CSO, are scheduled to present at the SVB Leerink CybeRx Series: Vaccine Forum on Monday, June 21, 2021 at 1:00 p.m. Eastern Time.
Please contact your SVB Leerink representative to schedule virtual one-on-one meetings with Vaxart during the respective conference.
About CybeRx Series: Vaccine Forum
The CybeRx Series: Vaccine Forum will include research scientists from large and emerging companies, perspective from the U.S. Food and Drug Administration, and internationally recognized experts in the fields of virology and immunology.
For further information, please visit: www.svbleerink.com
Note Regarding Forward-Looking Statements